Less than one year since the announcement of their $11 million Series A, Qualio - the trusted cloud quality management system software for the entire life sciences ecosystem - today announced their $50 million Series B funding round led by Tiger Global. Menlo Ventures also joined this round, alongside the following current Qualio investors: Frontline Ventures, MHS Capital, Operator Partners, Sorenson Ventures, and Storm Ventures.

With more than 250 life sciences customers worldwide, Qualio is the most trusted quality management software for teams launching and scaling life-saving products. Leading pharmaceutical, biotech, medical device, and clinical research organizations leverage Qualio's cloud-based quality management system software to unite their teams' processes and data. Qualio enables customers to deliver on the promise of quality and meet the complex regulatory compliance requirements without sacrificing speed.